MANGALAM DRUGS & ORGANICS LTD. - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, August 5, 2022

Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business: 1. Considered & approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A) 2. Amended Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated persons and immediate relatives of Designated persons in the securities of the company as per Regulation 9 of SEBI (Prohibition of Insider Trading), Regulations, 2015; (Annexure B) 3. Amended Policy on Criteria for Determining Materiality of Events as per Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements), Regulations, 2015 (Annexure C).